Bharat Biotech’s Covaxin gets drug regulator approval for 6-12 year olds

The Drugs Controller General of India (DCGI) has given Bharat Biotech’s Covid vaccine Covaxin restricted emergency use authorisation for children between the age of 6-12 […]

COVID-19 vaccine: Bharat Biotech’s US partner Ocugen submits ‘Master File’ on Covaxin to FDA

Indian vaccine manufacturer Bharat Biotech’s American partner Ocugen submitted a ‘Master File’ to the US Food and Drug Administration on Tuesday in regards to its Coronavirus vaccine candidate– Covaxin. […]

Bharat Biotech has refused to supply doses to Delhi “under government instructions”

Covaxin maker Bharat Biotech has refused to supply doses to Delhi “under instructions” from the central government, Deputy Chief Minister Manish Sisodia alleged today, accusing […]

Bharat Biotech has been supplying Covaxin directly to 14 states

Bharat Biotech, Hyderabad based vaccine manufacturer has been supplying its COVID-19 vaccine ‘Covaxin’ directly to 14 states beginning May 1. In a tweet joint managing […]

Bharat Biotech has announced a scaling up of its manufacturing capacity to produce 700 million doses of Covaxin annually.

Inactivated vaccines, while highly safe, are extremely complex and expensive to manufacture, resulting in lower yields when compared to live virus vaccines. The vaccine has […]